Nospharma

Nospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University. We aim t... Read more